PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
18-Dec-2025 Revvity to Present at J.P. Morgan Healthcare Conference Businesswire
18-Dec-2025 Syremis Therapeutics Launches with $165M to Develop Best-in-Class Medicines for Mental Health Conditions Businesswire
18-Dec-2025 Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature Businesswire
18-Dec-2025 Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development Businesswire
18-Dec-2025 QurAlis Invited to Present at 44th Annual J.P. Morgan Healthcare Conference Businesswire
18-Dec-2025 Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Disease Registry to Advance Real-World Evidence in Neurodegenerative Care Businesswire
18-Dec-2025 Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq Businesswire
18-Dec-2025 Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer Businesswire
18-Dec-2025 BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma Businesswire
18-Dec-2025 Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector Celltrion
18-Dec-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
18-Dec-2025 Babson Diagnostics Wins Best Abstract Award at 2025 EFLM Preanalytical Conference ACCESS Newswire
18-Dec-2025 Hidden Viruses: Amoebae as a Water Safety “Trojan Horse” KL Krems
18-Dec-2025 BC Platforms and GeneVault partner to unlock access to large-scale real-world and genomic data from under-represented populations BC Platforms, GeneVault
18-Dec-2025 Brainomix AI Technology Reveals Efficacy of Novel Neuroprotective Drug Candidate in Severe Acute Ischemic Stroke Patients Brainomix AI
18-Dec-2025 Orum Therapeutics Secures Approximately US$100 Million to Accelerate Development of Leading Degrader Antibody Conjugate Programs to Treat Serious Diseases Businesswire
18-Dec-2025 Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment Businesswire
18-Dec-2025 SGD Pharma Zhanjiang Becomes China’s First Glass Manufacturer to Achieve ISO 14021 Certification for PCR Packaging SGD Pharma
18-Dec-2025 PureTech Appoints Robert Lyne as Chief Executive Officer PureTech
18-Dec-2025 numares Health enters ASEAN region with regulatory approval in Malaysia and first contract win for AXINON ® LDLp Test System numares Health